Parvin Asset Management’s Labcorp LH Stock Holding History

Parvin Asset Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10	Closed	-$2.33K	–	340
2025 Q1	$2.33K	Buy	+10	New	+$2.43K	﹤0.01%	317

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Parvin Asset Management's LH Position: Q2 2025 in Review

Parvin Asset Management sold out of Labcorp (LH) in Q2 2025, closing a stake of 10 shares — an estimated $2.33K sold.

Parvin Asset Management first reported a position in LH in Q1 2025 and held it in 1 quarter. The position peaked at $2.33K in Q1 2025. 973 funds tracked by Wall St. Rank hold LH as of Q2 2025.

Parvin Asset Management reported no remaining Labcorp position as of Q2 2025 after selling out during the quarter.
Parvin Asset Management sold 10 Labcorp shares in Q2 2025, an estimated $2.33K.
Parvin Asset Management first reported a position in Labcorp in Q1 2025 and held it in 1 quarter.
Parvin Asset Management's Labcorp position peaked at $2.33K in Q1 2025.
973 funds tracked by Wall St. Rank held Labcorp as of Q2 2025.

Based on Parvin Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.